Aortic hyporeactivity to norepinephrine induced by lipopolysaccharide in cirrhotic rats: Beneficial effects of a non-steroidal anti-inflammatory drug coupled with a nitric oxide donor

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 1, 2001, Pages 70-78

  Lefilliatre, Pascale ^a   Sogni, Philippe ^a,b   Bertrand, Viviane ^b   Del Soldato, Piero ^c   Pateron, Dominique ^a   Moreau, Richard ^a   Lebrec, Didier ^a  

^a BEAUJON HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c NicOx SA   (France)

Author keywords

Cirrhosis; Endotoxin; Nitric oxide; Nitric oxide synthase; Non steroidal anti inflammatory drug; Portal hypertension

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; IBUPROFEN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; N(G) NITROARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ENZYME RELEASE; HEART RATE; LIVER CIRRHOSIS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; STOMACH BLOOD FLOW; VASODILATATION;

EID: 0035143807     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02386.x     Document Type: Article

References (51)

1. A prospective study of bacterial infection in patients with cirrhosis
2. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: Relevance of ascitic fluid protein concentration
3. Septic shock in patients with cirrhosis: Hemodynamic and metabolic characteristics and intensive care unit outcome
4. Increased sensitivity to endotoxemia in cirrhotic rats
5. New insights into the regulation of inducible nitric oxide synthesis
6. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock
7. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway
8. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo
9. Hyperdynamic circulation of liver disease 40 years later: Pathophysiology and clinical consequences
10. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
11. The role of nitric oxide in the hyperdynamic syndrome associated with portal hypertension
12. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
13. Endothelium-dependent vascular hyporesponsiveness without nitric oxide synthase induction in aortas of cirrhotic rats
14. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats
15. Upregulation of endothelial constitutive NOS. A major role in the increased NO production in cirrhotic rats
16. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide in experimental cirrhosis
17. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites
18. Increased serum nitrite and nitrate levels in patients with cirrhosis: Relationship to endotoxemia
19. Long-lasting NO overproduction in cirrhotic patients with spontaneous bacterial peritonitis
20. Effect of a new non-steroidal anti-inflammatory drug, nitroflurbiprofen, on the expression of inducible nitric oxide synthase in rat neutrophils
21. Inhibition of inducible nitric oxide synthase expression by novel nonsteroidal anti-inflammatory derivates with gastrointestinal-sparing properties
22. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension
23. Effects of prostaglandin inhibition on systemic and hepatic hemodynamics in patients with cirrhosis of the liver
24. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs
25. The dose-dependent effect of misoprostol on indomethacin-induced renal dysfunction in well compensated cirrhosis
26. Novel nonsteroidal anti-inflammatory drug derivates with markedly ulcerogenic properties in the rat
27. A nitric oxide-releasing anti-inflammatory drug accelerates gastric ulcer healing in rats
28. Markedly reduced intestinal toxicity of a diclofenac derivate
29. Systemic and splanchnic hemodynamic effects of molsidomine in rats with carbon tetrachloride-induced cirrhosis
30. Effects of molsidomine, a long acting venous dilator on portal hypertension. A hemodynamic study in patients with cirrhosis
31. Animal models of portal hypertension
32. Hemodynamic characterization of chronic bile duct ligated rats: Effects of pentobarbital sodium
33. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hyopertensive rats
34. W-nitro-L-arginine: A potent inhibitor of endothelium-derived relaxing factor formation
35. Drugs which inhibit prostaglandin synthesis
36. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine
37. Protein measurement with the Folin phenol reagent
38. Hyporeactivity of mesenteric resistance arteries in portal hypertensive rats
39. Pathogenesis of arterial hypotension in cirrhotic rats with ascites: Role of endogenous nitric oxide
40. Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats
41. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats
42. In vitro hyporeactivity to methoxamine in portal hypertensive rats: Reversal by nitric oxide blockade
43. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat
44. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats
45. Reduction of gastrointestinal injury in acute endotoxic shock by flurbiprofen nitroxybutylester
46. Lack of effect of indomethacin on systemic and splanchnic haemodynamics in portal hypertensive rats
47. Inhibition by sodium nitroprusside of the expression of inducible nitric oxide synthase in rat neutrophils
48. Nitric oxide limits transcriptional induction of nitric oxide synthase in CNS glial cells
49. Effect of cyclic GMP-dependent vasodilators on the expression of inducible nitric oxide synthase in vascular smooth muscle cells: Role of cyclic AMP
50. Amplification of nitric oxide synthase expression by nitric oxide in interleukin 1 beta-stimulated rat mesangial cells
51. Induction and stabilization of IkBa by nitric oxide mediates inhibition of NF-kB